From Conjecture to Clarity
Supporting the Healthcare Industry
with Local Industry Knowledge
and Marketing Expertise
From Conjecture to Clarity
Supporting the Healthcare Industry
with Local Industry Knowledge
and Marketing Expertise
e-Projection is a fully integrated consulting firm based in Tokyo, Japan.
Our experienced team serves our clients, non-Japanese biotechnology and pharmaceutical companies, with a wide spectrum of penetrating insights into the local market.
Our expertise in the pharmaceutical industry spans all areas. We are a true one-stop shop consultancy for our clients to make strategic decisions about the Japanese market.
Our clients are industry leaders making well-informed decisions about entering markets. We help them understand the Japanese market, recognize threats and opportunities, and provide a clear idea of the value of their innovation in the Japanese market.
Leader
DVM, PhD, MBA,
Founder & President
We provide a full range of pricing and market access consultations from the planning stage to post-commercialization. Our clients are able to develop fully integrated global pricing strategies that contribute to both maximizing the value of their product and succeeding commercially in the Japanese market.
Leader
Advisor:
Pricing & Market Access
Our P&L forecast/project valuation capabilities are based on our broad experience in the local pharmaceutical market and cutting-edge valuation techniques. These capabilities will provide strategic implications to maximize the corporate value of our clients.
Leader
Advisor:
Sales & Marketing
Our deep experience in clinical trial design and our extensive network within the medical community are highly valued by clients seeking integrated global development strategies. We provide our clients with the best solutions to optimize local development plans and maximize the clinical value of the product in the Japanese market.
Leader
MD, PhD, MBA,
Chief Medical Officer
e-Projection carries out a full range of marketing research activities from KOL interviews and web-based quant surveys to secondary data collection and analysis. The local insights generated by this research help our clients understand unmet medical need in the marketplace as well as how to best adapt the profile of the local version of their product.
Leader
DVM, PhD, MBA,
Founder & President
We not only identify the key regulatory requirements needed for product approval, we offer our clients value maximization plans within the regulatory window of opportunity. We present multiple scenarios in order for our clients to understand the regulatory playing field in Japan.
Click here for details >We serve biotech, pharma, investors, and academic institutions who are interested in bringing their products and technologies to the Japanese market and/or seek business partners from the Chinese market. By applying our analytical capabilities in the BD process, we support our clients with the tools and strategies to best negotiate with their potential Japanese partners.
Click here for details >US-based biotech company developing phase II product in US/EU, trying to assess whether to expand development activities into Japan now or later. In planning for an IPO in a few months time, the company needed to ensure that investors understood the true global value of their product.
view more >US biotech company developing phase III product for treatment of a cardiac disease in a hospital setting. Seeking to investigate the Japanese market for their product, find local partners with expertise in the therapeutic area.
view more >Swiss-based pharmaceutical company seeking business opportunity to develop their product in Japan. Competitive products for the same disease already existed in the Japanese market. Client needed to assess the clinical value of their product and its potential to succeed in Japan, including any advantage over competitors.
view more >A German-based biotech in discussion with a Japanese company about the potential licensing of its product. The product targets the treatment of a disease with large unmet medical need currently receiving little treatment. The product was finishing its Phase III program in Europe with plans to submit the application for approval to the authorities.
view more >US-based biotech exploring how to obtain premium pricing for their medical device and drug, individually as well as their combination, for a treatment of eye diseases. Client also sought to gain an understanding of the various ways for reimbursement of this combination procedure.
view more >We understand the China market well. This market is growing significantly as the result of changes and improvements in the regulatory environment and better organization of intellectual property law.
A Chinese company seeking new technology looked to be introduced to the growing market of products from Japan
The client needed our services to overcome challenges associated with linguistic and cultural barriers.
Summary The current business environment around the biotechnology industry is increasingly challenging for the biotech companies to ensure access to capital, while out-licensing deals with Japanese companies could present an important alternative source of non-dilutive cash. Here, we have summarized the latest trends of the business development in Japan, focusing on the buy-side activities by […]
In market research, we should clearly define the target, study populations from which we collect data and information. The same goes for in-depth interviewing. When choosing which interviewees will participate in a research,we need to think carefully about what we want their results to mean and how we will use them in order to maximize […]
To achieve sound results from your pharmaceutical market research and to generate a sales forecast you need to start from a solid base, which is primarily based on strategic survey design and methodology. Without expert input your questionnaire may contain questions that are difficult to understand, lead to biased answers and to nonsense outcomes. That’s […]
Dyadic interviews, in which two participants are interviewed together, are becoming more popular in qualitative research, but are much less discussed in the methodological literature than individual and focus groups. For a couple of years, however, e-Projection have used dyadic interviews as a research method and learned the strengths and the potential pitfalls associated with […]
Focus Group is one of the critical components of market research. On the basis of our research experience in Japan, e-Projection believes that our focus group research can provide creative solutions to our clients, adopting a constructive approach to designing the discussion which addresses the core of an issue, and steering the discussion in the […]
We help non-Japanese pharma/biotech companies understand and expand into the Japanese market.